Created at 11:28 a.m. Aug, 20, 2024
Bulk Suggestion Bulk ID: mohannadkh10/08.20.24-11:28AM
Author: mohannadkh10
Related Note: 1474060077809 3
Rationale for change

This bulk suggestion is to update the cards that test "disorders of fibrinolysis"

- This topic is very very LY and personally want most of these cards to be deleted
- The term "Disorders of fibrinolysis" is only used in pathoma and it's hard for someone who don't use pathoma as their source to understand that it means "overactivity of plasmin", the current cards assume that we should know this

- Amboss uses the term "hyperfibrinolysis" instead which is easier to understand

- Disorder of fibrinolysis is an umbrella term that include both hyper and hypofibrinolysis and pathoma only talks about hyper and the cards only asks about hyper so i thought it's a good idea to add more clarity to the term this way


Source: AMBOSS - https://next.amboss.com/us/article/8T0Os2?q=plasmin%20overactivity#Z6742cc6332bfb0485107ad4b94d6f40a

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Empty field
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#Pathoma::04_Hemostasis::03_Other_Disorders_of_Hemostasis #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::04_Fibrinolysis_and_Inhibitors_of_Hemostasis #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::Pathoma_Hematology #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::19_Mixed_platelet_and_coagulation_disorders::*Disorders_of_Fibrinolysis #AK_Step1_v12::#Physeo::11_Pathology::10_HemeOnc_Pathology::03_HIT_DIC_Disorders_of_Fibrinolysis #AK_Step1_v12::^Systems::HemeOnc::Hematology #PANCE::EOR::Surgery #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::01_Coagulation #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield